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AntifungalAbstract In this work 9H-carbazole was utilized as a precursor to prepare new heterocyclic deriv-
atives. Treatment of carbazole 1 with ethyl acetoacetate gave ethyl 9H-carbazol-9-ylacetate 2. The
acetate ester derivative 2 was transformed into the 2-(9H-carbazol-9-yl)acetohydrazide 3 through
treatment with hydrazine hydrate. Reaction of compound 3 with sodium nitrite/HCl afforded
[(9H-carbazol-9-ylacetyl)amino]diazonium chloride 4. Compounds 3-[3-(9H-carbazol-9-ylace-
tyl)triazanylidene]pentane-2,4-dione 5 and ethyl 2-[3-(9H-carbazol-9-ylacetyl)triazanylidene]-3-
oxobutnoate 6 were obtained by reaction of compound 4 with acetylacetone and ethyl acetoacetate,
respectively. Treatment of compounds 5 and 6 with urea and phenylhydrazine afforded 5-[3-(9H-
carbazol-9-ylacetyl)triazanylidene]-4,6-dimethyl pyrimidin-2(5H)-one 7 and 4-[3-(9H-carbazol-9-yl
acetyl)triazanylidene]-5-methyl-2-phenyl-2,4-dihydro-3H-pyrazol-3-one 8, respectively. The struc-
tures of the synthesized compounds were characterized by IR, 1H NMR, 13C NMR and elemental
analysis. All synthesized products were tested and evaluated as antimicrobial agents.
ª 2011 Production and hosting by Elsevier B.V. on behalf of King Saud University. This is an open access
article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).1. Introduction
Microorganisms cause different kinds of diseases to humans
and animals. Discovery of chemotherapeutic agents played a
very important role in controlling and preventing such dis-
eases. Chemotherapeutic agents are isolated either from living
organisms known as antibiotic like penicillin and tetracyclineor they are chemical compounds prepared by chemists such
as sulfa drugs (Rajakumar et al., 2008; Menor-Salva´n et al.,
2009). Microorganisms have the ability to develop resistance
to these chemotherapeutic agents and such strains which are
resistance cause major problems in the treatment of microbial
infections (Salimon et al., 2010a). For this reason, searching
for new antimicrobial agent is continuous process and great
efforts have been employed to ﬁnd new antibiotic or new
chemical compounds with good antimicrobial activity which
might be suitable to be used as chemotherapeutic agents
(Moellering et al., 2007; Rajakumar et al., 2009).
Carbazole and its derivatives are an important type of
nitrogen containing aromatic heterocyclic compounds, possess
desirable electronic and charge-transport properties, as well as
large p-conjugated system, the various functional groups are
easily introduced into the structurally rigid carbazolyl ring.
Figure 1 Structures of some biologically active carbazole
compounds.
S782 N. Salih et al.These characteristics result in the extensive potential applica-
tions of carbazole-based derivatives in the ﬁeld of photoelectri-
cal materials (Morin et al., 2005), dyes (Kim et al., 2007),Figure 2 Synthetic protcol tosupramolecular recognition (Zhou et al., 2009) and medicinal
chemistry (antitumor, antimicrobial, antihistaminic, antioxida-
tive, anti-inﬂammatory, psychotropic agents, etc.) (Kno¨lker
and Reddy, 2002; Mi et al., 2007; Cai et al., 2009; Bai et al.,
2007). Carbazole ring is present in a variety of naturally occur-
ring medicinally active substances (Kno¨lker and Reddy, 2002).
For example, the Carbazomycins are an unprecedented class of
antibiotics with a carbazole framework (Kno¨lker et al., 2003;
Hagiwara et al., 2000), Carbazomycins A and B (Fig. 1) inhibit
the growth of phytopathogenic fungi and have antibacterial
and anti-yeast activities and Murrayafoline A, which was iso-
lated from Murraya euchrestifolia Hayata collected in Taiwan
(Cuong et al., 2008), exhibited strong fungicidal activity
against Cladosporium cucumerinum at the dose of 12.5 lg.
In view of the above mentioned ﬁndings and as continua-
tion of our efforts to identify new candidates that may be ofsynthesis compounds (2–8).
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2010b; Salimon and Salih, 2010a). We report here the synthesis
of some carbazole-based azole derivatives in order to investi-
gate their antimicrobial activity (Fig. 2).2. Experimental
2.1. Measurements
Melting points were determined in open glass capillary tube on
a Gallen-Kamp MFB-595 apparatus (United Kingdom) and
are uncorrected. The IR spectra were taken on a Perkin-Elmer
FT-IR 1650 (United States), using samples in KBr disks. The
1H NMR (400 MHz) and 13C NMR (100 MHz) spectra were
recorded on JEOL JNM-ECP 400 spectrometer (Japan) using
DMSO-d6 as solvent and TMS as the internal standard, the
chemical shifts are expressed in dppm. Elemental microanalysis
was performed on a Perkin Elmer CHN-2400 analyzer (United
States). All reactions were followed by TLC (Silica gel, alumi-
num sheets 60 F254, Merck).
2.2. Synthesis
2.2.1. Ethyl 9H-carbazol-9-ylacetate 2
To a stirred solution of carbazole 1 (0.02 mol) in ethanol
(25 mL), ethyl chloroacetate (0.02 mol) was added drop wise
and the mixture was left stirred at room temperature overnight
then the reaction mixture was poured into ice water (100 mL).
The crude product was ﬁltered off, washed with water and
recrystalized from ethanol to give compound 2 as colorless nee-
dles. Yield: 81%; m.p. 80–81 C; IR (KBr, cm1): 3090 (C–H
stretching of aromatic ring), 2987 and 2865 (C–H streching of
aliphatic group), 1745 (C‚O stretching), 1046 (C–O–C stretch-
ing); 1H NMR (400 MHz, DMSO-d6, d/ppm): 8.05 (1H,
d, J= 8.23, Ar-H), 8.01 (1H, d, J= 16.04, Ar-H), 7.65 (1H,
d, J= 8.25, Ar-H), 7.54 (1H, d, J= 16.10, Ar-H), 7.43 (1H,
t, J= 7.98, Ar-H), 7.37 (1H, t, J= 8.15, Ar-H), 7.26 (1H,
t, J= 7.95, Ar-H), 7.18 (1H, t, J= 8.11, Ar-H), 3.96 (2H,
q, J= 8.65, CH2CH3), 3.76 (2H, s, CH2), 2.10 (3H,
t, J= 12.12, CH2CH3);
13C NMR (100 MHz-DMSO-d6,
d/ppm): 169.32, 137.25, 137.09, 136.85, 136.03, 135.90,
135.14, 134.60, 133.79, 133.05, 132.11, 131.27, 130.98, 13.15,
12.99, 10.52; Anal. Calcd. for C16H15NO2 (253.11 g/mol): C,
75.87; H, 5.97; N, 5.53. Found: C, 75.88; H, 5.96; N, 5.52.
2.2.2. 2-(9H-Carbazol-9-yl)acetohydrazide 3
To a solution of the acetate ester 2 (0.01 mol) in absolute eth-
anol (25 mL), hydrazine hydrate 98% (0.021 mol) was added
and the reaction mixture was heated under reﬂux for 4 h. Then
reaction mixture was left stirring overnight. The separated so-
lid product was ﬁltered, dried and recrystalized from ethanol/
H2O (2:2) to yield compound 3 as a white crystals. Yield: 73%;
m.p. 130–131 C; IR (KBr, cm1): 3045 (C–H stretching of
aromatic ring), 3330, 3274 (NHNH2 stretching), 1645 (C‚O
stretching); 1H NMR (400 MHz, DMSO-d6, d/ppm): 8.84
(2H, s, NH2, D2O exchangeable), 8.21 (1H, s, NH, D2O
exchangeable), 8.12 (1H, d, J= 11.89, Ar-H), 7.95 (1H,
d, J= 7.88, Ar-H), 7.54 (1H, d, J= 7.96, Ar-H), 7.52 (1H,
d, J= 12.08, Ar-H), 7.24 (1H, t, J= 11.79, Ar-H), 7.16
(1H, t, J= 12.69, Ar-H), 7.05 (1H, t, J= 7.78, Ar-H), 6.91
(1H, t, J= 8.09, Ar-H), 3.73 (2H, s, CH2);
13C NMR(100 MHz-DMSO-d6, d/ppm): 171.45, 137.14, 136.95, 136.70,
136.34, 135.87, 135.56, 135.21, 134.71, 133.10, 132.89, 132.34,
131.23, 10.66; Anal. Calcd. for C14H13N3O (255.27 g/mol):
C, 65.87; H, 5.13; N, 16.46. Found: C, 65.86; H, 5.14; N, 16.45.
2.2.3. 3-[3-(9H-Carbazol-9-ylacetyl)triazanylidene]pentane-
2,4-dione 5
A mixture of the diazonium salt 4 (0.01 mol), sodium acetate
(0.01 mol) and acetylacetone (0.01 mol) in ethanol (25 mL)
was stirring together in ice bath for 12 h. Then, the reaction
mixture was poured into crushed ice and the solid deposits
was ﬁltered and recrystalized from ethanol/H2O (2:2) to give
the desired product 5. Yield: 60%; m.p. 191–192 C; N,
12.55; IR (KBr, cm1): 3234 (N–H stretching), 3056 (C–H
stretching of aromatic ring), 2930, 2867 (C–H stretching of ali-
phatic group), 1702, 1645 (C‚O stretching), 1620 (C‚N
stretching); 1H NMR (400 MHz, DMSO-d6, d/ppm): 8.23,
8.19 (2H, 2s, 2NH, D2O exchangeable), 8.10 (1H,
d, J= 11.90, Ar-H), 7.98 (1H, d, J= 7.79, Ar-H), 7.85 (1H,
d, J= 11.59, Ar-H), 7.72 (1H, d, 15.69, Ar-H), 7.65 (1H, t,
J= 12.11, Ar-H), 7.55 (1H, t, J= 11.67, Ar-H), 7.46 (1H,
t, J= 11.79, Ar-H), 7.38 (1H, t, J= 12.20, Ar-H), 3.75 (2H,
s, CH2), 2.37, 2.34 (6H, 2s, 2CH3);
13C NMR (100 MHz-
DMSO-d6, d/ppm): 173.84, 171.69, 170.35, 137.66, 137.52,
136.39, 136.12, 135.68, 134.78, 133.65, 133.13, 132.50, 131.90,
130.41, 13.25, 13.02, 12.65, 9.98; Anal. Calcd. for
C19H18N4O4 (366.37 g/mol): C, 62.29; H, 4.95; N, 15.29.
Found C, 62.30; H, 4.94; N, 15.28.
2.2.4. Ethyl 2-[3-(9H-carbazol-9-ylacetyl)triazanylidene]-3-
oxobutnoate 6
The same method described for the synthesis of compound 5
but using ethyl acetoacetate (0.01 mol) instead of acetyl ace-
tone. Yield: 52%; m.p. 111-113 C; IR (KBr, cm1): 3321
(N–H stretching), 3089 (C–H stretching of aromatic ring),
2924, 2831 (C–H stretching of aliphatic group), 1735, 1718,
1640 (C‚O stretching), 1622 (C‚N stretching); 1H NMR
(400 MHz, DMSO-d6, d/ppm): 8.24, 8.20 (2NH, 2s, 2H, D2O
exchangeable), 8.08 (1H, d, J= 8.39, Ar-H), 7.97 (1H, d,
J= 7.92, Ar-H), 7.88 (1H, d, J= 8.09, Ar-H), 7.80 (1H, d,
J= 7.57, Ar-H), 7.71 (1H, t, J= 7.68, Ar-H), 7.57 (1H,
t, J= 7.75, Ar-H), 7.50 (1H, t, J= 7.81, Ar-H), 7.43 (1H, t,
J= , 7.89, Ar-H), 3.93 (2H, q, J= 7.49, CH2CH3), 3.73
(2H, s, CH2), 2.12 (3H, t, J= 7.90, CH2CH3), 1.98 (3H, s,
CH3);
13C NMR (100 MHz-DMSO-d6, d/ppm): 173.34,
172.65, 171.90, 138.43, 138.15, 138.03, 137.51, 137.22, 136.81,
135.10, 134.76, 133.94, 133.06, 132.38, 131.09, 18.34, 13.94,
13.61, 12.38; Anal. Calcd. for C20H20N4O5 (396.40 g/mol): C,
60.60; H, 5.09; N, 14.13. Found: C, 60.59; H, 5.10; N, 14.12.
2.2.5. 5-[3-(9H-Carbazol-9-ylacetyl)triazanylidene]-4,6-
dimethylpyrimidin-2(5H)-one 7
To a solution of compound 6 (0.01 mol) in ethanol (20 mL),
urea (0.01 mol) was added and the reaction mixture was
reﬂuxed for 6 h. The reaction mixture was concentrated to
approximately half of its volume and allowed to cool to room
temperature. The solid product was ﬁltered using suction
pump, washed with thoroughly with water, dried and recrys-
talized from ethanol (Menor-Salva´n et al., 2009). Yield:
60%; m.p. 152–153 C; IR (KBr, cm1): 3225 (N–H
stretching), 3090 (C–H stretching of aromatic ring), 2931,
2840 (C–H stretching of aliphatic group), 1645 (C‚O stretch-
S784 N. Salih et al.ing), 1624 (C‚N stretching); 1H NMR (400 MHz, DMSO-d6,
d/ppm): 8.40, 8.38 (2NH, 2s, 2H , D2O exchangeable), 8.10
(1H, d, J= 8.11, Ar-H), 7.96 (1H, d, J= 7.79, Ar-H), 7.85
(1H, d, J= 7.92, Ar-H), 7.78 (1H, d, J= 8.15, Ar-H), 7.69
(1H, t, J= 7.78, Ar-H), 7.55 (1H, t, J= 7.71, Ar-H), 7.46
(1H, t, J= 7.76, Ar-H), 7.41 (1H, t, J= 7.77, Ar-H), 3.17
(2H, s, CH2), 2.49, 2.239 (6H, 2s, 2CH3);
13C NMR
(100 MHz-DMSO-d6, d/ppm): 172.31, 170.89, 138.57, 138.31,
137.58, 137.44, 136.02, 135.23, 135.14, 134.84, 134.46, 134.06,
133.18, 132.35, 18.15, 13.09, 13.03, 12.98; Anal. Calcd. for
C20H18N6O3 (390.40 g/mol): C, 61.53; H, 4.65; N, 21.53.
Found: C, 61.52; H, 4.66; N, 21.52.
2.2.6. 4-[3-(9H-Carbazol-9-yl acetyl)triazanylidene]-5-methyl-
2-phenyl-2,4-dihydro-3H-pyrazol-3-one 8
A mixture of compound 6 (0.01 mol), anhydrous sodium ace-
tate (0.01 mmol) and phenylhydrazine (0.01 mol) in ethanol
(25 mL) was heated under reﬂux for 24 h. The reaction mixture
was concentrated, diluted with water and stored in a refriger-
ator. The separated solid was ﬁltered, washed with ether, dried
and recrystalized from ethanol. Yield: 70%; m.p. 230–231 C;
IR (KBr, cm1): 3313 (N–H stretching), 3026 (C–H stretching
of aromatic ring), 2924, 2836 (C–H stretching of aliphatic
group), 1642 (C‚O stretching), 1622 (C‚N stretching); 1H
NMR (400 MHz, DMSO-d6, d/ppm): 8.54, 8.31 (2NH, 2s,
2H , D2O exchangeable), 8.05 (1H, d, J= 7.95, Ar-H), 7.94
(1H, d, J= 8.17, Ar-H), 7.80 (1H, d, J= 8.12, Ar-H), 7.75
(2H, m, J= 8.54, Ar-H), 7.60 (1H, t, J= 7.85, Ar-H), 7.56
(2H, m, J= 8.67, Ar-H), 7.45 (1H, t, J= 8.23, Ar-H), 7.39
(2H, m, H= 7.92, Ar-H), 7.30 (2H, m, J= 8.58, Ar-H),
3.15 (2H, s, CH2), 2.90 (3H, s, CH3);
13C NMR (100 MHz-
DMSO-d6, d/ppm): 173.31, 172.40, 140.78, 140.66, 140.27,
139.40, 138.90, 138.42, 138.12, 137.62, 137.23, 137.11, 136.83,
136.50, 136.32, 135.71, 134.62, 133.60, 133.05, 132.12, 131.51,
12.75, 12.10, 11.98, 10.03; Anal. Calcd. for C24H20N6O3
(440.45 g/mol): C, 65.45; H, 4.58; N, 19.08. Found: C, 65.46;
H, 4.59; N, 19.09.3. Results and discussion
3.1. Chemistry
The synthetic procedure adopted to obtain the target com-
pounds are outlined in Fig. 2. Reaction of compound 1 with
ethyl chloroacetate in ethanol, leading to ethyl 9H-carbazol-
9-ylacetate 2. The IR spectrum of product 2 showed a sharp
medium absorption bands at 2987, 2865, and 1745 cm1,
which are characteristic bands for aliphatic and carbonyl
groups. The 1H NMR spectrum of compound 2 revealed the
appearance of triplet at d 2.10 ppm and quartet at d
3.96 ppm assigned to CH2CH3 group. The reaction of com-
pound 2 with hydrazine hydrate in reﬂuxing ethanol gave 2-
(9H-carbazol-9-yl)acetohydrazide 3. Furthermore, reaction of
compound 3 with sodium nitrite in conc. HCl gave the diazo-
nium salt 4. The characteristic IR absorption bands of com-
pound 3 appeared at 3330, 3274 and 1645 cm1 due to NH2,
N–H and C‚O groups. The spectrum of compound 3 revealed
two D2O-exchangable singlets at d 8.21 and 8.84 ppm assigned
to one N–H and NH2 proton (Salimon et al., 2010c). The
13C
NMR spectra of compounds 2 and 3 showed signals at d
169.32 and 171.45, respectively, assigned to C‚O groups. Be-side this, reﬂuxing of diazonium salt 4 with either acetyl ace-
tone or ethyl acetoacetate in the presence of sodium acetate
and by using ethanol as solvent afforded 3-[3-(9H-carbazol-
9-ylacetyl)triazanylidene]pentane-2,4-dione 5 and ethyl 2-[3-
(9H-carbazol-9-ylacetyl)triazanylidene]-3-oxobutnoate 6,
respectively (Salimon et al., 2010d). The IR spectrum of com-
pound 5 showed characteristic absorption band at 3234 cm1
due to N–H group besides to carbonyl absorption bands at
1702 and 1645 cm1. Its 1H NMR spectrum revealed two
D2O-exchangable singlets at d 8.19 and 8.23 ppm due to two
NH protons, in addition to three singlets at d 2.34, 2.37 and
3.75 ppm assignable for two methyl and one methylene group
protons, respectively (Salih et al., 2010; Salimon et al., 2011).
The analytical and 13C NMR data are in agreement with the
proposed structure. Furthermore, the chemical structure of 6
was established on the basis of its elemental analysis and spec-
tral data. Its IR spectrum showed absorption bands at 3321,
1735, 1718 and 1640 cm1 due to NH and C‚O groups (Sal-
imon and Salih, 2010b). Its 1H NMR spectrum displayed trip-
let band at d 2.12 ppm and quartet at 3.93 ppm corresponding
CH2CH3 group. The
13C NMR spectrum was characterized by
signals at d 2.38, 13.61, 13.94 and 18.34 ppm assigned to CH3,
CH2CH3 and –C‚N– carbons, respectively. The reaction of
compound 5 with urea and compound 6 with phenyl hydrazine
gave 5-[3-(9H-carbazol-9-ylacetyl)triazanylidene]-4,6-dimethyl
pyrimidin-2(5H)-one 7 and 4-[3-(9H-Carbazol-9-yl acetyl)tria-
zanylidene]-5-methyl-2-phenyl-2,4-dihydro-3H-pyrazol-3-one
8, respectively (Salimon et al., 2011a). Structure of 7 was con-
ﬁrmed on the basis of elemental analysis and spectral studies.
The IR spectrum showed characteristic amide C‚O band at
1645 cm1. The 1H NMR spectrum showed two singlets at d
2.23 and 2.49 ppm assigned to methyl group protons (Salih
et al., 2011). The elemental analysis and 13C NMR data were
consistent with the proposed structure. On the other hand,
the structure of compound 8 was conﬁrmed on the basis of
its element analysis and spectral data. The IR spectrum
showed bands at 3213, 1642 and 1622 cm1 due to NH,
C‚O and C‚N groups, respectively. Its 1H NMR spectrum
showed, in addition to the expected signals, singlet signal at
d 2.90 ppm assigned to one methyl group protons.
3.2. Antibacterial evaluation
Antimicrobials are one of a very important category of drug;
these classes of drugs are prescribed right from simple infec-
tions to the serious diseases and also in life threatening infec-
tions like meningitis. So it is quite clear from the spectrum
of use that these categories of drugs are very important from
medical point of view (Salimon et al., 2009). But microbial
resistance towards the drug creates a very serious problem; be-
cause of this development of resistance many drugs are now
useless which were very effective before. Moreover, the toxic
effects produced by these antibiotics are also reducing their sig-
niﬁcance (Salimon et al., 2010e). So the need for new antimi-
crobial is always be their. All the newly synthesized
compounds were evaluated for their in vitro antibacterial
activity against Staphylococcus aureus (ATCC 6538), Bacillus
subtilis (NRRL B-14819) and Micrococcus luteus (ATCC
21881) as examples of Gram positive bacteria and Escherichia
coli (ATCC 25922), Pseudomonas aeruginosa (ATCC 27853)
and Klebsiella pneumonia (clinical isolate) as examples of Gram
negative bacteria. Disk diffusion method (Cruickshank et al.,
Table 1 Minimal inhibitory concentration (MIC, lg/mL) of the synthesized compounds against some Gram positive and Gram
negative bacterial strains.
Compound S. aureus ATCC
6538
B. subtilis NRRL
B-14819
M. luteus
ATCC 21881
E. coli
ATCC 25922
P. aeruginosa
ATCC 27853
K. pneumonia
(clinical isolate)
1 –a – – – – –
2 3.3 5.3 6.6 21.1 13.1 25.6
3 5.0 4.4 6.2 11.2 15.7 7.4
5 5.1 3.4 7.1 16.5 25.6 7.2
6 3.7 2.9 6.1 18.1 4.1 8.8
7 2.8 2.3 2.9 10.3 21.3 8.3
8 1.1 1.2 3.1 6.4 20.2 23.6
Ampicillin trihydrateb 0.2 0.39 0.1 0.3 0.2 0.25
a (–): Totally inactive.
b Ampicillin trihydrate (standard broad spectrum antibiotic).
Table 2 Minimal inhibitory concentrations (MIC, lg/mL) of the synthesized compounds against some fungal strains.
Compound C. albicans C. tropicalis C. krusei A. niger A. fumigatus T. rubrum
1 –a – – – – –
2 23.4 – – – 19.8 –
3 13.4 – – – – –
5 20.1 – – – 11.4 –
6 17.5 – – – 16.2 –
7 10.8 – – – 8.7 –
8 9.6 – – – 10.3 –
Clotrimazoleb 3.12 6.25 3.12 12.5 6.25 3.12
Miconazolec 6.25 3.12 3.12 6.25 12.5 6.25
a (–): Totally inactive.
b Clotrimazole (standard broad spectrum antifungal agent).
c Miconazole (standard broad spectrum antifungal agent).
Synthesis and antimicrobial activities of 9H-carbazole derivatives S7851975; Collins, 1976) was used for determination of the preli-
minary antibacterial activity. Disks measuring 6.25 mm in
diameter were punched from Whatman no.1 ﬁlter paper.
Batches of 100 disks were dispensed to each screw-capped bot-
tle and sterilized by dry heat at 140 C for an hour. The tested
compounds were prepared with different concentrations using
DMSO. 1 mL containing 100 times the amount of chemical in
each disk was added to each bottle, which contained 100 disks.
Disks of each concentration were placed in triplicate in nutri-
ent agar medium seeded with fresh bacteria separately. The
incubation was carried out at 37 C for 24 h. Ampicillin trihy-
drate was used as a standard drug at a concentration of 10 lg/
mL. Solvent and growth controls were kept and zones of inhi-
bition were noted. From the MIC (lg/mL) data presented in
Table 1, it can be seen that the synthesized compounds dis-
played variable inhibitory effects on the growth of tested Gram
positive and Gram negative bacterial strains. Ampicillin trihy-
drate was used as a reference drug. In general, the tested com-
pounds revealed better activity against the Gram positive
rather than the Gram negative bacteria. Among the Gram po-
sitive bacteria tested, two strains namely; S. aureus and B. sub-
tilis showed relatively high sensitivity towards the tested
compounds. In this view, compounds 7 and 8 were equipotent
to ampicillin against S. aureus and B. subtilis. With regard to
the activity against M. luteus, the best activity was displayed
by compound 7. On the other hand, investigation of antibacte-
rial activity of the active compounds against the three testedGram negative strains revealed that compound 8 was able to
produce moderate growth inhibitory activity against E. coli.
Whereas, compounds 3 and 7, exhibit mild activity against
the same microorganism. Meanwhile, the tested microorgan-
isms P. aeruginosa and K. pneumonia strains were proved to
be weakly sensitive to the tested compounds. Among these,
compounds 3 and 6 showed moderate growth inhibitory pro-
ﬁles against these microorganisms.
3.3. Antifungal evaluation
Compounds 1–8 screened for their in vitro antifungal activity
against Candida albicans, Candida tropicalis and Candida kru-
sei as representatives of fungi and Aspergillus niger, Aspergillus
fumigatus and Tricophyton rubrum as examples of moulds in
DMSO by the serial plate dilution method (Khan, 1997; Var-
ma, 1998). All the fungal and mould strains were clinical iso-
lates, identiﬁed with conventional morphological and
biochemical methods. Clotrimazole and Miconazole (antifun-
gals) were used as reference drugs. Sabouraud’s agar media
were prepared by dissolving peptone (1 g), D-glucose (4 g),
and agar (2 g) in distilled water (100 ml) and adjusting the
pH to 5.7. Normal saline was used to make a suspension of
the spore of fungal strain for lawning. A loopful of particular
fungal strain was transferred to 3 ml saline to get a suspension
of the corresponding species. Agar media (20 mL) was poured
into each petri dish. Excess suspension was decanted and the
S786 N. Salih et al.plates were dried by placing in an incubator at 37 C for 1 h.
Using an agar punch wells were made into each well labeled.
A control was also prepared in triplicate and maintained at
37 C for 3–4 days. Antifungal activity was determined by
measuring the diameter of the inhibition zone. The MIC
(lg/mL) values of the tested compounds against the tested fun-
gal strains are recorded in Table 2. Concerning the antifungal
activity of the tested compounds, only two organisms namely;
C. albicans and A. fumigatus showed certain sensitivity against
some of the tested compounds, whereas the rest of the fungal
strains were totally insensitive to the same compounds. Com-
pounds 7 and 8 exhibited moderate growth inhibitory action
on A. fumigatus and C. albicans microorganisms.
4. Conclusion
The antimicrobial results revealed that compound 7 and 8 have
promising activities against some tested microorganisms which
may be due to the increase the lipophilic character of the mol-
ecules, which facilitate the crossing through the biological
membrane of the microorganism and thereby inhibit their
growth. In conclusion, we reported here a simple and conve-
nient route for the synthesis of some new derivatives based
on carbazole moiety for antimicrobial evaluation.Acknowledgements
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